Skip to main content

Signed · Germany · Pharma and biotech

HRV Pharma agrees to acquire Phatebo.

HRV Global Life Sciences, the Hyderabad-based pharmaceutical group trading as HRV Pharma, signed an agreement on 3 November 2026, through its Amsterdam subsidiary New Horizon Pharma B.V., to buy all shares of Phatebo GmbH, a medicines supply company in Hilzingen, Germany, from the US-listed ZeroStack Corp. for EUR 2.15 million. Closing is subject to German foreign direct investment clearance. It was signed on 3 November 2026. It had not completed by 10 November 2026.

SigningDay 100

Signing 3 November 2026

Target
Phatebo GmbH ·Hilzingen, Germany
Type
Acquisition
Announced
3 November 2026
Signed
3 November 2026
Value
EUR 2.15 million
People
Not stated in the release
Last checked
10 November 2026

The people side in Germany

Octagon runs payroll in Germany for international buyers, with or without a local entity of their own.

Get the briefing

Deals into Europe lists public facts with their sources, checked every working day by Octagon Professionals International. Corrections go to info@octagon.nl and are made within one working day. How we track deals.

Enabling organisations to operate across borders with clarity, compliance, and trust.

All deals into Europe